Biological and therapeutic implications of a unique subtype of NPM1 mutated AML

Molecular heterogeneity of acute myeloid leukaemia (AML) across patients is a major challenge for prognosis and therapy. Here, the authors show that NPM1 mutated AML is a heterogeneous class, consisting of two subtypes which exhibit distinct molecular characteristics, differentiation state, patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arvind Singh Mer, Emily M. Heath, Seyed Ali Madani Tonekaboni, Nergiz Dogan-Artun, Sisira Kadambat Nair, Alex Murison, Laura Garcia-Prat, Liran Shlush, Rose Hurren, Veronique Voisin, Gary D. Bader, Corey Nislow, Mattias Rantalainen, Soren Lehmann, Mark Gower, Cynthia J. Guidos, Mathieu Lupien, John E. Dick, Mark D. Minden, Aaron D. Schimmer, Benjamin Haibe-Kains
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/a1a1fb4ad66d4a54b1ec1c09785a2551
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a1a1fb4ad66d4a54b1ec1c09785a2551
record_format dspace
spelling oai:doaj.org-article:a1a1fb4ad66d4a54b1ec1c09785a25512021-12-02T10:52:48ZBiological and therapeutic implications of a unique subtype of NPM1 mutated AML10.1038/s41467-021-21233-02041-1723https://doaj.org/article/a1a1fb4ad66d4a54b1ec1c09785a25512021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-21233-0https://doaj.org/toc/2041-1723Molecular heterogeneity of acute myeloid leukaemia (AML) across patients is a major challenge for prognosis and therapy. Here, the authors show that NPM1 mutated AML is a heterogeneous class, consisting of two subtypes which exhibit distinct molecular characteristics, differentiation state, patient survival and drug response.Arvind Singh MerEmily M. HeathSeyed Ali Madani TonekaboniNergiz Dogan-ArtunSisira Kadambat NairAlex MurisonLaura Garcia-PratLiran ShlushRose HurrenVeronique VoisinGary D. BaderCorey NislowMattias RantalainenSoren LehmannMark GowerCynthia J. GuidosMathieu LupienJohn E. DickMark D. MindenAaron D. SchimmerBenjamin Haibe-KainsNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Arvind Singh Mer
Emily M. Heath
Seyed Ali Madani Tonekaboni
Nergiz Dogan-Artun
Sisira Kadambat Nair
Alex Murison
Laura Garcia-Prat
Liran Shlush
Rose Hurren
Veronique Voisin
Gary D. Bader
Corey Nislow
Mattias Rantalainen
Soren Lehmann
Mark Gower
Cynthia J. Guidos
Mathieu Lupien
John E. Dick
Mark D. Minden
Aaron D. Schimmer
Benjamin Haibe-Kains
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
description Molecular heterogeneity of acute myeloid leukaemia (AML) across patients is a major challenge for prognosis and therapy. Here, the authors show that NPM1 mutated AML is a heterogeneous class, consisting of two subtypes which exhibit distinct molecular characteristics, differentiation state, patient survival and drug response.
format article
author Arvind Singh Mer
Emily M. Heath
Seyed Ali Madani Tonekaboni
Nergiz Dogan-Artun
Sisira Kadambat Nair
Alex Murison
Laura Garcia-Prat
Liran Shlush
Rose Hurren
Veronique Voisin
Gary D. Bader
Corey Nislow
Mattias Rantalainen
Soren Lehmann
Mark Gower
Cynthia J. Guidos
Mathieu Lupien
John E. Dick
Mark D. Minden
Aaron D. Schimmer
Benjamin Haibe-Kains
author_facet Arvind Singh Mer
Emily M. Heath
Seyed Ali Madani Tonekaboni
Nergiz Dogan-Artun
Sisira Kadambat Nair
Alex Murison
Laura Garcia-Prat
Liran Shlush
Rose Hurren
Veronique Voisin
Gary D. Bader
Corey Nislow
Mattias Rantalainen
Soren Lehmann
Mark Gower
Cynthia J. Guidos
Mathieu Lupien
John E. Dick
Mark D. Minden
Aaron D. Schimmer
Benjamin Haibe-Kains
author_sort Arvind Singh Mer
title Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
title_short Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
title_full Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
title_fullStr Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
title_full_unstemmed Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
title_sort biological and therapeutic implications of a unique subtype of npm1 mutated aml
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a1a1fb4ad66d4a54b1ec1c09785a2551
work_keys_str_mv AT arvindsinghmer biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT emilymheath biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT seyedalimadanitonekaboni biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT nergizdoganartun biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT sisirakadambatnair biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT alexmurison biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT lauragarciaprat biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT liranshlush biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT rosehurren biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT veroniquevoisin biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT garydbader biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT coreynislow biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT mattiasrantalainen biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT sorenlehmann biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT markgower biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT cynthiajguidos biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT mathieulupien biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT johnedick biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT markdminden biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT aarondschimmer biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
AT benjaminhaibekains biologicalandtherapeuticimplicationsofauniquesubtypeofnpm1mutatedaml
_version_ 1718396548761518080